Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myotonic dystrophies.

Chin-Chang Huang1, Hung-Chou Kuo

  • 1Department of Neurology, Chang Gung Memorial Hospital, Taipei, Taiwan, ROC. cch0537@adm.cgmh.org.tw

Chang Gung Medical Journal
|November 4, 2005
PubMed
Summary

Myotonic dystrophies (DM) are a group of genetic disorders. Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are caused by repeat expansions in specific genes, requiring molecular genetic analysis for diagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A clinically feasible framework to estimate tau pathology and clinical-biological discordance in the Alzheimer's disease spectrum.

Alzheimer's research & therapy·2026
Same author

Taiwan Clinical Practice Guidelines for Myasthenia Gravis.

Acta neurologica Taiwanica·2026
Same author

ADAS-Cog11 performance as a surrogate of tau PET burden in an Asian Alzheimer's disease cohort.

Journal of Alzheimer's disease : JAD·2026
Same author

Epidemiological characteristics and natural history of porphyria - a twenty-year population-based analysis in Taiwan.

Orphanet journal of rare diseases·2025
Same author

Visual interpretation of [<sup>18</sup>F]Florzolotau Tau-PET imaging for differentiating alzheimer's disease and progressive supranuclear palsy.

European journal of nuclear medicine and molecular imaging·2025
Same author

The modified spatial context memory test for assessing cognitive aging in middle-aged and older adults.

Neuroscience research·2025

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Myotonic dystrophies (DM) encompass a spectrum of genetic disorders, including DM1, DM2, and DM3.
  • DM1 results from CTG repeat expansion in the DMPK gene (chromosome 19); DM2 from CCTG repeat expansion in the ZNF9 gene (chromosome 3).
  • Clinical presentations of DM1 and DM2 are similar, necessitating molecular genetic confirmation.

Purpose of the Study:

  • To review the genetic basis and clinical characteristics of myotonic dystrophies.
  • To discuss diagnostic approaches and recent findings, particularly concerning DM3.
  • To explore genotype-phenotype correlations and epidemiological data, especially in Taiwan.

Main Methods:

  • Review of existing literature on myotonic dystrophies.
  • Analysis of genetic mutations (CTG and CCTG repeat expansions).
  • Correlation of clinical symptoms with genetic findings and neuroimaging (MRI).

Main Results:

  • DM1 and DM2 diagnosis relies on molecular genetic testing due to overlapping symptoms.
  • DM3 is a recently identified multisystem disorder linked to chromosome 15q21-24.
  • Central nervous system manifestations in DM1 correlate with white matter lesions but not directly with CTG repeat numbers in blood cells.
  • Repeat size contraction occurs with paternal transmission of large repeats; variability in muscle differentiation exists in congenital DM1.

Conclusions:

  • Accurate diagnosis of myotonic dystrophies requires molecular genetic analysis.
  • Further research is needed to fully understand genotype-phenotype correlations, especially regarding CNS involvement and repeat length.
  • Epidemiological data, like the lower prevalence of DM1 in Taiwan, highlights regional variations.

Related Experiment Videos